Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis

Mahomed Yunus S. Moosa, George J. Alangaden, Elias Manavathu, Pranatharthi H. Chandrasekar

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume49
Issue number1
StatePublished - Feb 6 2002

Fingerprint

Aspergillosis
Amphotericin B
Aspergillus
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Moosa, M. Y. S., Alangaden, G. J., Manavathu, E., & Chandrasekar, P. H. (2002). Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. Journal of Antimicrobial Chemotherapy, 49(1), 209-213.

Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. / Moosa, Mahomed Yunus S.; Alangaden, George J.; Manavathu, Elias; Chandrasekar, Pranatharthi H.

In: Journal of Antimicrobial Chemotherapy, Vol. 49, No. 1, 06.02.2002, p. 209-213.

Research output: Contribution to journalArticle

Moosa, MYS, Alangaden, GJ, Manavathu, E & Chandrasekar, PH 2002, 'Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis', Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 209-213.
Moosa MYS, Alangaden GJ, Manavathu E, Chandrasekar PH. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. Journal of Antimicrobial Chemotherapy. 2002 Feb 6;49(1):209-213.
Moosa, Mahomed Yunus S. ; Alangaden, George J. ; Manavathu, Elias ; Chandrasekar, Pranatharthi H. / Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. In: Journal of Antimicrobial Chemotherapy. 2002 ; Vol. 49, No. 1. pp. 209-213.
@article{ddeeb68113b043a28e2e413106d0db73,
title = "Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis",
abstract = "Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.",
author = "Moosa, {Mahomed Yunus S.} and Alangaden, {George J.} and Elias Manavathu and Chandrasekar, {Pranatharthi H.}",
year = "2002",
month = "2",
day = "6",
language = "English (US)",
volume = "49",
pages = "209--213",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis

AU - Moosa, Mahomed Yunus S.

AU - Alangaden, George J.

AU - Manavathu, Elias

AU - Chandrasekar, Pranatharthi H.

PY - 2002/2/6

Y1 - 2002/2/6

N2 - Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.

AB - Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.

UR - http://www.scopus.com/inward/record.url?scp=0036156656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036156656&partnerID=8YFLogxK

M3 - Article

C2 - 11751792

AN - SCOPUS:0036156656

VL - 49

SP - 209

EP - 213

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 1

ER -